BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 21417679)

  • 21. Topical treatment with thiazolidinediones, activators of peroxisome proliferator-activated receptor-gamma, normalizes epidermal homeostasis in a murine hyperproliferative disease model.
    Demerjian M; Man MQ; Choi EH; Brown BE; Crumrine D; Chang S; Mauro T; Elias PM; Feingold KR
    Exp Dermatol; 2006 Mar; 15(3):154-60. PubMed ID: 16480422
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Phosphodiesterase 7A inhibitor ASB16165 impairs proliferation of keratinocytes in vitro and in vivo.
    Goto M; Kadoshima-Yamaoka K; Murakawa M; Yoshioka R; Tanaka Y; Inoue H; Murafuji H; Kanki S; Hayashi Y; Nagahira K; Ogata A; Nakatsuka T; Fukuda Y
    Eur J Pharmacol; 2010 May; 633(1-3):93-7. PubMed ID: 20132810
    [TBL] [Abstract][Full Text] [Related]  

  • 23. T cell clones from psoriasis skin lesions can promote keratinocyte proliferation in vitro via secreted products.
    Prinz JC; Gross B; Vollmer S; Trommler P; Strobel I; Meurer M; Plewig G
    Eur J Immunol; 1994 Mar; 24(3):593-8. PubMed ID: 8125129
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Systemic treatment of psoriatic patients with bexarotene decreases epidermal proliferation and parameters for inflammation, and improves differentiation in lesional skin.
    Smit JV; de Jong EM; van Hooijdonk CA; Otero ME; Boezeman JB; van de Kerkhof PC
    J Am Acad Dermatol; 2004 Aug; 51(2):257-64. PubMed ID: 15280845
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The anti-apoptotic protein G1P3 is overexpressed in psoriasis and regulated by the non-coding RNA, PRINS.
    Szegedi K; Sonkoly E; Nagy N; Németh IB; Bata-Csörgo Z; Kemény L; Dobozy A; Széll M
    Exp Dermatol; 2010 Mar; 19(3):269-78. PubMed ID: 20377629
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunofluorescence localization of nuclear retinoid receptors in psoriasis versus normal human skin.
    Karlsson T; Rollman O; Vahlquist A; Törmä H
    Acta Derm Venereol; 2004; 84(5):363-9. PubMed ID: 15370702
    [TBL] [Abstract][Full Text] [Related]  

  • 27. microRNA-mediated keratinocyte hyperproliferation in psoriasis vulgaris.
    Ichihara A; Jinnin M; Yamane K; Fujisawa A; Sakai K; Masuguchi S; Fukushima S; Maruo K; Ihn H
    Br J Dermatol; 2011 Nov; 165(5):1003-10. PubMed ID: 21711342
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antagonism of epidermal growth factor receptor tyrosine kinase ameliorates the psoriatic phenotype in organ-cultured skin.
    Varani J; Lateef H; Fay K; Elder JT
    Skin Pharmacol Physiol; 2005; 18(3):123-31. PubMed ID: 15897684
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sensory neurons increase keratinocyte proliferation through CGRP release in a tissue engineered in vitro model of innervation in psoriasis.
    Pepin R; Ringuet J; Beaudet MJ; Bellenfant S; Galbraith T; Veillette H; Pouliot R; Berthod F
    Acta Biomater; 2024 Jul; 182():1-13. PubMed ID: 38750917
    [TBL] [Abstract][Full Text] [Related]  

  • 30. hMena: altered expression in psoriatic skin.
    Cardinali G; Kovacs D; Mastrofrancesco A; Cota C; Donati P; Cordiali-Fei P; Francesconi F; Bonifati C
    Arch Dermatol Res; 2013 Dec; 305(10):933-8. PubMed ID: 23604962
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A simple technique for high-throughput screening of drugs that modulate normal and psoriasis-like differentiation in cultured human keratinocytes.
    Pol A; Bergers M; van Ruissen F; Pfundt R; Schalkwijk J
    Skin Pharmacol Appl Skin Physiol; 2002; 15(4):252-61. PubMed ID: 12218287
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MiR-217 is down-regulated in psoriasis and promotes keratinocyte differentiation via targeting GRHL2.
    Zhu H; Hou L; Liu J; Li Z
    Biochem Biophys Res Commun; 2016 Feb; 471(1):169-76. PubMed ID: 26826389
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Induction of normal and psoriatic phenotypes in submerged keratinocyte cultures.
    Van Ruissen F; de Jongh GJ; Zeeuwen PL; Van Erp PE; Madsen P; Schalkwijk J
    J Cell Physiol; 1996 Aug; 168(2):442-52. PubMed ID: 8707880
    [TBL] [Abstract][Full Text] [Related]  

  • 34. All-trans retinoic acid stimulates growth of adult human keratinocytes cultured in growth factor-deficient medium, inhibits production of thrombospondin and fibronectin, and reduces adhesion.
    Varani J; Nickoloff BJ; Dixit VM; Mitra RS; Voorhees JJ
    J Invest Dermatol; 1989 Oct; 93(4):449-54. PubMed ID: 2476509
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tumour necrosis factor-alpha does not influence proliferation and differentiation of healthy and psoriatic keratinocytes in a skin-equivalent model.
    Fransson J
    Acta Derm Venereol; 2000; 80(6):416-20. PubMed ID: 11243633
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Investigation of Omega-3 Polyunsaturated Fatty Acid Biological Activity in a Tissue-Engineered Skin Model Involving Psoriatic Cells.
    Simard M; Rioux G; Morin S; Martin C; Guérin SL; Flamand N; Julien P; Fradette J; Pouliot R
    J Invest Dermatol; 2021 Oct; 141(10):2391-2401.e13. PubMed ID: 33857488
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Etanercept restores a differentiated keratinocyte phenotype in psoriatic human skin: a morphological study.
    Donetti E; Gualerzi A; Ricceri F; Pescitelli L; Bedoni M; Prignano F
    Exp Dermatol; 2012 Jul; 21(7):549-51. PubMed ID: 22716254
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Retinoic acid co-treatment aggravates severity of dioxin-induced skin lesions in hairless mice via induction of inflammatory response.
    Rudyak SG; Usakin LA; Tverye EA; Orekhov AS; Belushkina NN; Paus R; Paltsev MA; Panteleyev AA
    Biochem Biophys Res Commun; 2018 Dec; 506(4):854-861. PubMed ID: 30389142
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The proteasome maturation protein POMP increases proteasome assembly and activity in psoriatic lesional skin.
    Zieba BA; Henry L; Lacroix M; Jemaà M; Lavabre-Bertrand T; Meunier L; Coux O; Stoebner PE
    J Dermatol Sci; 2017 Oct; 88(1):10-19. PubMed ID: 28728908
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Topical retinoic acid alters the expression of cellular retinoic acid-binding protein-I and cellular retinoic acid-binding protein-II in non-lesional but not lesional psoriatic skin.
    Karlsson T; Virtanen M; Sirsjö A; Rollman O; Vahlquist A; Törmä H
    Exp Dermatol; 2002 Apr; 11(2):143-52. PubMed ID: 11994141
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.